Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Cancer Research|April 1, 1995
Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cellsV Gandhi, S Mineishi, P Huang, et al.
The American Journal of Medicine|September 1, 1986
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaH M Kantarjian, E H Estey, W Plunkett, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|March 1, 1993
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemiaH M Kantarjian, M Beran, A Ellis, et al.
The New England Journal of Medicine|January 22, 1987
Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant diseaseH A Lehman, L O Lehman, P K Rustagi, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Seminars in Oncology|June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson HospitalM J Keating, E Estey, W Plunkett, et al.
Blood|March 21, 1998
Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemiaU Consoli, I El-Tounsi, A Sandoval, et al.
Cancer Treatment Reports|February 1, 1980
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA)M Valdivieso, E C Moore, A M Burgess, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Cancer Research|April 1, 1995
Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cellsV Gandhi, S Mineishi, P Huang, et al.
The American Journal of Medicine|September 1, 1986
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaH M Kantarjian, E H Estey, W Plunkett, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|March 1, 1993
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemiaH M Kantarjian, M Beran, A Ellis, et al.
The New England Journal of Medicine|January 22, 1987
Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant diseaseH A Lehman, L O Lehman, P K Rustagi, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
Seminars in Oncology|June 1, 1985
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson HospitalM J Keating, E Estey, W Plunkett, et al.
Blood|March 21, 1998
Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemiaU Consoli, I El-Tounsi, A Sandoval, et al.
Cancer Treatment Reports|February 1, 1980
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA)M Valdivieso, E C Moore, A M Burgess, et al.
Pageof 25